Braig S - Search Results

1

MOF nanoparticles coated by lipid bilayers and their uptake by cancer cells.

Wuttke S, Braig S, Preiß T, Zimpel A, Sicklinger J, Bellomo C, Rädler JO, Vollmar AM, Bein T. Wuttke S, et al. Among authors: braig s. Chem Commun (Camb). 2015 Nov 11;51(87):15752-5. doi: 10.1039/c5cc06767g. Chem Commun (Camb). 2015. PMID: 26359316

2

Indirubin derivative 6BIO suppresses metastasis.

Braig S, Kressirer CA, Liebl J, Bischoff F, Zahler S, Meijer L, Vollmar AM. Braig S, et al. Cancer Res. 2013 Oct 1;73(19):6004-12. doi: 10.1158/0008-5472.CAN-12-4358. Epub 2013 Aug 14. Cancer Res. 2013. PMID: 23946383

3

Pretubulysin: a new option for the treatment of metastatic cancer.

Braig S, Wiedmann RM, Liebl J, Singer M, Kubisch R, Schreiner L, Abhari BA, Wagner E, Kazmaier U, Fulda S, Vollmar AM. Braig S, et al. Cell Death Dis. 2014 Jan 16;5(1):e1001. doi: 10.1038/cddis.2013.510. Cell Death Dis. 2014. PMID: 24434509 Free PMC article.

4

Simplified pretubulysin derivatives and their biological effects on cancer cells.

Kubisch R, von Gamm M, Braig S, Ullrich A, Burkhart JL, Colling L, Hermann J, Scherer O, Müller R, Werz O, Kazmaier U, Vollmar AM. Kubisch R, et al. Among authors: braig s. J Nat Prod. 2014 Mar 28;77(3):536-42. doi: 10.1021/np4008014. Epub 2014 Jan 17. J Nat Prod. 2014. PMID: 24437936

5

Pharmacological characterization of actin-binding (-)-doliculide.

Foerster F, Braig S, Chen T, Altmann KH, Vollmar AM. Foerster F, et al. Among authors: braig s. Bioorg Med Chem. 2014 Sep 15;22(18):5117-22. doi: 10.1016/j.bmc.2014.03.003. Epub 2014 Mar 15. Bioorg Med Chem. 2014. PMID: 24679674

6

The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancer.

Braig S, Bischoff F, Abhari BA, Meijer L, Fulda S, Skaltsounis L, Vollmar AM. Braig S, et al. Biochem Pharmacol. 2014 Sep 15;91(2):157-67. doi: 10.1016/j.bcp.2014.07.009. Epub 2014 Jul 25. Biochem Pharmacol. 2014. PMID: 25069048

7

A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.

Eirich J, Braig S, Schyschka L, Servatius P, Hoffmann J, Hecht S, Fulda S, Zahler S, Antes I, Kazmaier U, Sieber SA, Vollmar AM. Eirich J, et al. Among authors: braig s. Angew Chem Int Ed Engl. 2014 Nov 17;53(47):12960-5. doi: 10.1002/anie.201406577. Epub 2014 Sep 26. Angew Chem Int Ed Engl. 2014. PMID: 25256790

8

Validating Metal-Organic Framework Nanoparticles for Their Nanosafety in Diverse Biomedical Applications.

Wuttke S, Zimpel A, Bein T, Braig S, Stoiber K, Vollmar A, Müller D, Haastert-Talini K, Schaeske J, Stiesch M, Zahn G, Mohmeyer A, Behrens P, Eickelberg O, Bölükbas DA, Meiners S. Wuttke S, et al. Among authors: braig s. Adv Healthc Mater. 2017 Jan;6(2). doi: 10.1002/adhm.201600818. Epub 2016 Nov 15. Adv Healthc Mater. 2017. PMID: 27863166

9

A Dual Topoisomerase Inhibitor of Intense Pro-Apoptotic and Antileukemic Nature for Cancer Treatment.

Meier C, Steinhauer TN, Koczian F, Plitzko B, Jarolim K, Girreser U, Braig S, Marko D, Vollmar AM, Clement B. Meier C, et al. Among authors: braig s. ChemMedChem. 2017 Mar 7;12(5):347-352. doi: 10.1002/cmdc.201700026. Epub 2017 Feb 8. ChemMedChem. 2017. PMID: 28099785

10

Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT-1 Controlled Pathways.

Gleissner CM, Pyka CL, Heydenreuter W, Gronauer TF, Atzberger C, Korotkov VS, Cheng W, Hacker SM, Vollmar AM, Braig S, Sieber SA. Gleissner CM, et al. Among authors: braig s. ACS Cent Sci. 2019 Jul 24;5(7):1170-1178. doi: 10.1021/acscentsci.9b00266. Epub 2019 Jun 18. ACS Cent Sci. 2019. PMID: 31403069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page